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Abstract
Background	Malaysia	has	introduced	the	free	Pap	smear	as	the	primary	cervical	cancer	screening
program	since	the	1960s	but	has	only	achieved	the	national	coverage	of	22%.	The	coverage	would	be
much	lower	in	the	rural	communities	especially	in	Sarawak	where	many	villages	are	still	inaccessible
by	road,	and	communities	are	living	in	low	resource	settings.	In	this	study,	we	have	evaluated
Qiagen’s	careHPV	system	as	a	point-of-care	HPV	diagnostic	test	together	with	the	visualization	using
acetic	acid	(VIA)	in	the	isolated	community	in	the	Highland	of	Bario	which	are	predominantly	from	the
Kelabit	ethnicity.	Methods	Women	attending	the	cervical	cancer	outreach	program	were	recruited.
Consent	was	obtained	and	a	cervical	swab	was	clinician-collected	and	screened	for	High-risk	HPV	DNA
using	the	careHPV	system.	Cervical	examination	using	VIA	was	offered	to	all	women	age	<50-year.
hrHPV	positive	women	were	recruited	during	their	follow-up	session	and	the	second	cervical	swab	was
collected	for	HPV	genotyping	using	consensus	primer-nested	PCR	to	elucidate	the	infecting	HPV
genotypes.	Results	Seventy-five	women	from	the	age	of	27-83	(mean	age	55)	attended	the	cervical
cancer	screening	clinic	and	8%	(n=6/75)	of	them	were	positive	for	hrHPV.	Only	33	women	were
screened	using	VIA	and	21.2%	(n=7/33)	were	found	to	be	positive.	A	majority	of	the	women	(58.6%)
were	above	the	age	of	50-year	and	not	recommended	for	VIA	to	be	performed.	Thus,	it	was	not
feasible	to	correlate	the	results	obtained	from	the	HPV	DNA	test	and	VIA.	Only	four	hrHPV	positive
women	returned	for	follow-up	and	genotyping	revealed	HPV52	in	2	of	four	women	tested	suggesting
that	HPV52	may	be	the	predominant	genotype	in	Bario.	Conclusions	The	careHPV	system	is	portable
and	can	be	used	in	low	resource	settings	as	long	as	reliable	electricity	is	available.	We	found	that
careHPV	DNA	test	is	more	objective	compared	to	VIA	and	can	be	used	to	screen	women	outside	the
recommended	eligible	age.		This	is	especially	true	for	older	women	in	the	rural	who	have	never	had
any	form	of	cervical	cancer	screening	before.
Introduction
Cervical	cancer	is	the	second	most	common	killer	in	Malaysian	women	after	breast	cancer.		Around
1682	women	are	diagnosed	with	the	disease	annually	and	944	die	from	the	disease	(1).		The	Ministry
of	Health,	Malaysia	has	introduced	free	Pap	smear	as	the	primary	cervical	cancer	screening	test	since
